causal

Uncertainty in drug data benefits manufacturers

Because only about a third of cancer drugs have reliable survival data—many being approved on uncontrolled single-arm studies showing tumor shrinkage without a control group—there is large uncertainty about real benefit, and this uncertainty benefits manufacturers because tolerating uncertainty lets drugs reach market that otherwise could not.

causalpending

Speaker

Vinay Prasad

Evidence Quote

“that uncertainty benefits the makers of the product. They want the uncertainty”

Source

Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty— EconTalk
Created: 6/13/2026, 3:32:57 AM

Your notes

Loading notes...